Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: A desmoid tumor (also known as aggressive fibromatosis) is a rare, non-cancerous growth arising from connective tissue that does not spread to distant organs but can be locally invasive and damaging to surrounding structures. Because desmoid tumors are often sensitive to hormones, they are frequently managed with targeted hormonal therapies like Tamoxifen and Zolodex to slow their growth. What exactly is a desmoid tumor? A desmoid tumor is a rare soft tissue tumor that originates in the fibroblasts, which are cells responsible for creating connective tissue.
TL;DR: A desmoid tumor (also known as aggressive fibromatosis) is a rare, non-cancerous growth arising from connective tissue that does not spread to distant organs but can be locally invasive and damaging to surrounding structures. Because desmoid tumors are often sensitive to hormones, they are frequently managed with targeted hormonal therapies like Tamoxifen and Zolodex to slow their growth.
A desmoid tumor is a rare soft tissue tumor that originates in the fibroblasts, which are cells responsible for creating connective tissue. Unlike malignant cancers, desmoid tumors do not metastasize (spread to other parts of the body). However, they are classified as "locally aggressive" because they can grow into nearby muscles, nerves, and blood vessels, often causing significant pain and functional impairment.
The impact of a desmoid tumor depends heavily on its location. While they can occur anywhere, they frequently affect:
Desmoid tumors are very rare, with an estimated incidence of 2 to 4 cases per million people annually. They most commonly appear in adults between the ages of 30 and 40, though they can develop at any age. Research indicates that women are slightly more likely to be diagnosed with a desmoid tumor than men, and there is a known association between these tumors and the genetic condition Familial Adenomatous Polyposis (FAP).
Unlike traditional cancers, desmoid tumors are characterized by a lack of metastatic potential. Key clinical features include:
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.